3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof
    1.
    发明申请
    3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof 有权
    3-取代的3,4-二氢 - 噻吩并[2,3-d]嘧啶-4-酮衍生物,的制备和用途

    公开(公告)号:US20060142317A1

    公开(公告)日:2006-06-29

    申请号:US10539708

    申请日:2003-12-17

    IPC分类号: A61K31/519 C07D498/14

    CPC分类号: C07D495/14

    摘要: The invention relates to 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives which are substituted in position 3 by 5-membered heteroaryl which may be fused to an aryl or heteroaryl radical, where the heteroaryl and, if appropriate, the fused aryl or heteroaryl radical may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, —NH2, —N(R6)2, —NH(R6), aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl, where the substituents aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, —NH2, —N(R6)2 and —NH(R6). The preparation and use of these derivatives, especially for therapeutic purposes, e.g. for the treatment of depressions, are likewise described.

    摘要翻译: 本发明涉及在3位被5元杂芳基取代的3,4-二氢 - 噻吩并[2,3-d]嘧啶-4-酮衍生物,其可以与芳基或杂芳基稠合,其中杂芳基和 如果合适,稠合的芳基或杂芳基可以具有1,2或3个彼此独立地选自C 1-5 - 烷基,C 1-5 - 烷氧基,C 1-5 - 烷硫基,卤素,CN,卤代-C 1-5 - 烷基,卤代C 1-5 - 烷氧基,羟基,-NH 2,-N(R 6)2,-NH(R 6),芳基,芳氧基,芳烷基,芳烷氧基和杂芳基,其中取代基芳基, 芳氧基,芳烷基,芳烷氧基和杂芳基可以具有1,2或3个选自C 1-5 - 烷基,C 1-5 - 烷氧基,C 卤代C 1 -C 5烷基,卤素,CN,卤代-C 1-5烷基,卤代-C 1-5烷氧基,羟基 ,-NH 2,-N(R 6)2和-NH(R 6)。 这些衍生物的制备和使用,特别是用于治疗目的,例如 为了处理凹陷,同样地描述。

    3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof
    2.
    发明授权
    3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof 有权
    3-取代的3,4-二氢 - 噻吩并[2,3-d]嘧啶-4-酮衍生物,的制备和用途

    公开(公告)号:US07491729B2

    公开(公告)日:2009-02-17

    申请号:US10539708

    申请日:2003-12-17

    CPC分类号: C07D495/14

    摘要: 3-Substituted 3,4-dihydrothieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof. The invention relates to 3,4-dihydrothieno[2,3-d]pyrimidin-4-one derivatives which are substituted in position 3 by 5-membered heteroaryl which may be fused to an aryl or heteroaryl radical, where the heteroaryl and, if appropriate, the fused aryl or heteroaryl radical may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, —NH2, —N(R6)2, —NH(R6), aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl, where the substituents aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, —NH2, —N(R6)2 and —NH(R6). The preparation and use of these derivatives, especially for therapeutic purposes, e.g. for the treatment of depressions, are likewise described.

    摘要翻译: 3-取代的3,4-二氢噻吩并[2,3-d]嘧啶-4-酮衍生物,的制备和用途。 本发明涉及在3位被5位杂芳基取代的3,4-二氢噻吩并[2,3-d]嘧啶-4-酮衍生物,其可以与芳基或杂芳基稠合,其中杂芳基和 稠合的芳基或杂芳基可以具有1,2或3个彼此独立地选自C 1-5 - 烷基,C 1-5 - 烷氧基,C 1-5 - 烷硫基,卤素,CN,卤代-C 1-5 - 烷基,卤代C 1-5 - 烷氧基,羟基,-NH 2,-N(R 6)2,-NH(R 6),芳基,芳氧基,芳烷基,芳烷氧基和杂芳基,其中芳基,芳氧基,芳烷基,芳烷氧基和杂芳基 可以具有1,2或3个彼此独立地选自C 1-5 - 烷基,C 1-5 - 烷氧基,C 1-5 - 烷硫基,卤素,CN,卤代C 1-5 - 烷基,卤代-C 1-5 - 烷氧基,羟基,-NH 2,-N(R 6)2和-NH(R 6)。 这些衍生物的制备和使用,特别是用于治疗目的,例如 为了处理凹陷,同样地描述。

    Carboxamide compounds and their use as calpain inhibitors
    5.
    发明申请
    Carboxamide compounds and their use as calpain inhibitors 有权
    羧酰胺化合物及其作为钙蛋白酶抑制剂的用途

    公开(公告)号:US20080234329A1

    公开(公告)日:2008-09-25

    申请号:US12070941

    申请日:2008-02-22

    IPC分类号: A61K31/4439 C07D401/00

    摘要: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, W, Y and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula I-A.a′ and I-A.a″ in which m, E, R1, R3a, R3b, R2, Ry, Rw and Rw6* have the meanings mentioned in the claims, n is 0, 1 or 2, the tautomers thereof and the pharmaceutically suitable salts thereof.

    摘要翻译: 本发明涉及新的羧酰胺化合物及其用于制备药物的用途。 羧酰胺化合物是钙蛋白酶(钙依赖性半胱氨酸蛋白酶)的抑制剂。 因此,本发明还涉及这些羧酰胺化合物用于治疗与升高的钙蛋白酶活性相关的病症的用途。 羧酰胺化合物是通式I的化合物,其中R 1,R 2,R 3,R 3,R 3, >,W,Y和X具有权利要求书和说明书中所述的含义,其互变异构体及其药学上合适的盐。 特别地,化合物具有通式IA.a'和IA.a“,其中m,E,R 1,R 3a,R 3b, R 2,R 2,R 2,W 2和R 6具有如下的含义: 权利要求书,n为0,1或2,其互变异构体及其药学上合适的盐。

    Carboxamide compounds and their use as calpain inhibitors
    6.
    发明授权
    Carboxamide compounds and their use as calpain inhibitors 有权
    羧酰胺化合物及其作为钙蛋白酶抑制剂的用途

    公开(公告)号:US09018206B2

    公开(公告)日:2015-04-28

    申请号:US13610975

    申请日:2012-09-12

    摘要: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula Ia and Ib in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2—CH2, CH2—CH2—CH2, N(Ry#)—CH2, N(Ry#)—CH2—CH2 or CH═CH—CH═, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.

    摘要翻译: 本发明涉及新的羧酰胺化合物及其用于制备药物的用途。 羧酰胺化合物是钙蛋白酶(钙依赖性半胱氨酸蛋白酶)的抑制剂。 因此,本发明还涉及这些羧酰胺化合物用于治疗与升高的钙蛋白酶活性相关的病症的用途。 羧酰胺化合物是通式I的化合物,其中R 1,R 2,R 3a,R 3b,R 4,Q,Y,A和X具有权利要求和说明书中所述的含义及其互变异构体及其药学上合适的盐。 特别地,化合物具有通式Ia和Ib,其中R1,r,R2b,R3a,R3b,R4,Y和X具有权利要求中提及的含义,包括其互变异构体及其药学上合适的盐。 在这些化合物中,优选其中Y为CH2-CH2,CH2-CH2-CH2,N(Ry#)-CH2,N(Ry#)-CH2-CH2或CH = CH-CH≡,各自任选具有1 或2个H原子被相同或不同的基团Ry取代,其中Ry和Ry#具有权利要求中提及的含义。

    CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS
    7.
    发明申请
    CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS 审中-公开
    羧酰胺化合物及其作为钙蛋白酶抑制剂的用途

    公开(公告)号:US20130150367A1

    公开(公告)日:2013-06-13

    申请号:US13610975

    申请日:2012-09-12

    摘要: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula Ia and Ib in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2—CH2, CH2—CH2—CH2, N(Ry#)—CH2, N(Ry#)—CH2—CH2 or CH═CH—CH═, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.

    摘要翻译: 本发明涉及新的羧酰胺化合物及其用于制备药物的用途。 羧酰胺化合物是钙蛋白酶(钙依赖性半胱氨酸蛋白酶)的抑制剂。 因此,本发明还涉及这些羧酰胺化合物用于治疗与升高的钙蛋白酶活性相关的病症的用途。 羧酰胺化合物是通式I的化合物,其中R 1,R 2,R 3a,R 3b,R 4,Q,Y,A和X具有权利要求和说明书中所述的含义及其互变异构体及其药学上合适的盐。 特别地,化合物具有通式Ia和Ib,其中R1,r,R2b,R3a,R3b,R4,Y和X具有权利要求中提及的含义,包括其互变异构体及其药学上合适的盐。 在这些化合物中,优选其中Y为CH2-CH2,CH2-CH2-CH2,N(Ry#)-CH2,N(Ry#)-CH2-CH2或CH = CH-CH =,各自任选具有1 或2个H原子被相同或不同的基团Ry取代,其中Ry和Ry#具有权利要求中提及的含义。

    Carboxamide compounds and their use as calpain inhibitors

    公开(公告)号:US09150553B2

    公开(公告)日:2015-10-06

    申请号:US12810795

    申请日:2008-12-29

    CPC分类号: C07D405/14 C07D491/052

    摘要: The present invention relates to novel carboxamide compounds of the formula I and their use for the manufacture of a medicament. The carboxamide compounds are prodrugs of inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. R1 is C1-C10-alkyl, C2-C10-alkenyl, C2-C10-alkynyl, C3-C7-cycloalkyl, C3-C7-cycloalkyl-C1-C4-alkyl, aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl, hetaryl-C1-C4-alkyl or hetaryl-C2-C6-alkenyl, R2 is C3-C7-cycloalkyl, C3-C7-cycloalkyl-C1-C4-alkyl, aryl, O-aryl, O—CH2-aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl, hetaryl-C1-C4-alkyl or hetaryl-C2-C6-alkenyl, R3a and R3b together form a moiety S-Alk-S, O-Alk-S or O-Alk-O, wherein Alk is linear C2-C5-alkandiyl, which may be unsubstituted or substituted with 1, 2, 3 or 4 radicals selected from C1-C4-alkyl or halogen; X is a radical of the formulae C(═O)—O—Rx1, C(═O)—NRx2Rx3, C(═O)—N(Rx4)—(C1-C6-alkylene)-NRx2Rx3, C(═O)—N(Rx4)NRx2Rx3, n is 0, 1 or 2, one of the variables Y1, Y2, Y3 or Y4 is a nitrogen atom, and the remaining variables Y1, Y2, Y3 or Y4 are CH; Ry is e.g. OH, SH, halogen, NO2, NH2, CN, CF3, CHF2, CH2F, O—CF3, O—CHF2, O—CH2F, COOH, OCH2COOH, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C4-alkyl, C1-C6-alkylthio etc. W is a radical of the formulae W1 or W2 which is linked via nitrogen: in which * means the linkage to the 6-membered heteroaromatic ring, and # means the linkage to R2, m is 0, 1 or 2, and Rw is e.g. OH, SH, halogen, NO2, NH2, CN, CF3, CHF2, CH2F, O—CF3, O—CHF2, O—CH2F, COOH, OCH2COOH.

    Carboxamide compounds and their use as calpain inhibitors
    10.
    发明授权
    Carboxamide compounds and their use as calpain inhibitors 有权
    羧酰胺化合物及其作为钙蛋白酶抑制剂的用途

    公开(公告)号:US08906941B2

    公开(公告)日:2014-12-09

    申请号:US12708662

    申请日:2010-02-19

    摘要: The present invention relates to novel carboxamide compounds and their use as a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity and to a method for the therapeutic and/or prophylactic treatment by administering an effective amount of at least one of these carboxamide compounds.The carboxamide compounds are compounds of the general formula I in which W—R2 is selected from and R1, R2, R3a, R3b, Y1, Y2, Y3, Y4, X, Q, m, k, Rw and Rw* have the meanings mentioned in the claims, the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y1, Y2, Y3 and Y4 are CRy, or one or two of the variables Y1 to Y4 are a nitrogen atom and the remaining variables are CRy, wherein the radicals Ry may be identical or different and have the meanings mentionend in the claims.

    摘要翻译: 本发明涉及新的羧酰胺化合物及其作为药物的用途。 羧酰胺化合物是钙蛋白酶(钙依赖性半胱氨酸蛋白酶)的抑制剂。 因此,本发明还涉及这些羧酰胺化合物用于治疗与钙蛋白酶活性升高相关的疾病的用途,以及通过施用有效量的这些羧酰胺化合物中的至少一种来进行治疗和/或预防性治疗的方法。 羧酰胺化合物是其中W-R2选自并且R 1,R 2,R 3a,R 3b,Y 1,Y 2,Y 3,Y 4,X,Q,m,k,Rw和Rw *具有通式I的化合物 权利要求中提及的其互变异构体及其药学上合适的盐。 在这些化合物中,优选其中Y1,Y2,Y3和Y4为CRy,或变量Y1至Y4中的一个或两个为氮原子,剩余的变量为CRy,其中基团Ry可以相同或不同,并且具有 意思是在权利要求中提及。